-
1
-
-
77956887499
-
Introduction
-
Macfarlane RG. Introduction. Br Med Bull 1977;33:183-185
-
(1977)
Br Med Bull
, vol.33
, pp. 183-185
-
-
Macfarlane, R.G.1
-
2
-
-
33645456050
-
Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture
-
Lowe GDO. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006;133: 232-250
-
(2006)
Br J Haematol
, vol.133
, pp. 232-250
-
-
Lowe, G.D.O.1
-
3
-
-
14044254724
-
Elevated clotting factor levels and venous thrombosis
-
DOI 10.1159/000083835
-
Bertina RM. Elevated clotting factor levels and venous thrombosis. Pathophysiol Haemost Thromb 2003;33:395-400. (Pubitemid 40278714)
-
(2003)
Pathophysiology of Haemostasis and Thrombosis
, vol.33
, Issue.5-6
, pp. 395-400
-
-
Bertina, R.M.1
-
4
-
-
0032942943
-
Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study
-
DOI 10.1111/j.1365-2141.1999.01317.x
-
Rumley A, Lowe GDO, Sweetnam PM, Yarnell JWG, Ford RP. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Study. Br J Haematol 1999;105:110-116 (Pubitemid 29197151)
-
(1999)
British Journal of Haematology
, vol.105
, Issue.1
, pp. 110-116
-
-
Rumley, A.1
Lowe, G.D.2
Sweetnam, P.M.3
Yarnell, J.W.G.4
Ford, R.P.5
-
5
-
-
0036847634
-
Von Willebrand factor and coronary heart disease: Prospective study and meta-analysis
-
Whincup P, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, et al. Von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Europ Heart J 2002;23:1764-1770
-
(2002)
Europ Heart J
, vol.23
, pp. 1764-1770
-
-
Whincup, P.1
Danesh, J.2
Walker, M.3
Lennon, L.4
Thomson, A.5
Appleby, P.6
-
6
-
-
0036908576
-
Coagulation factors, inflammation markers, and venous thromboembolism: The longitudinal investigation of thromboembolism etiology (LITE)
-
DOI 10.1016/S0002-9343(02)01345-1, PII S0002934302013451
-
Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR. Coagulation factors, inflammation markers, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Med 2002;113:636-642 (Pubitemid 36015799)
-
(2002)
American Journal of Medicine
, vol.113
, Issue.8
, pp. 636-642
-
-
Tsai, A.W.1
Cushman, M.2
Rosamond, W.D.3
Heckbert, S.R.4
Tracy, R.P.5
Aleksic, N.6
Folsom, A.R.7
-
7
-
-
37549068918
-
ABO (H) blood groups and vascular disease: A systematic review and meta-analysis
-
Wu O, Bayoumi N, Vickers MA, Clark P. ABO (H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008;6:62-69
-
(2008)
J Thromb Haemost
, vol.6
, pp. 62-69
-
-
Wu, O.1
Bayoumi, N.2
Vickers, M.A.3
Clark, P.4
-
8
-
-
0042671199
-
Decreased mortality of ischaemic heart disease among carriers of haemophilia
-
DOI 10.1016/S0140-6736(03)14021-4
-
Sramek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003;362:351-354 (Pubitemid 36945057)
-
(2003)
Lancet
, vol.362
, Issue.9381
, pp. 351-354
-
-
Sramek, A.1
Kriek, M.2
Rosendaal, F.R.3
-
9
-
-
0035669048
-
Factor IX and thrombosis
-
DOI 10.1046/j.1365-2141.2001.03186.x
-
Lowe GDO. Factor IX and thrombosis. Br J Haematol 2001;115:507-513 (Pubitemid 34015639)
-
(2001)
British Journal of Haematology
, vol.115
, Issue.3
, pp. 507-513
-
-
Lowe, G.D.O.1
-
10
-
-
1942436221
-
Mendelian randomization: Prospects, potentials, and limitations
-
DOI 10.1093/ije/dyh132
-
Davey Smith G, Ebrahim S. Mendelian randomization: prospects, potentials and limitations. Int J Epidemiol 2004; 33:30-42. (Pubitemid 38528650)
-
(2004)
International Journal of Epidemiology
, vol.33
, Issue.1
, pp. 30-42
-
-
Smith, G.D.1
Ebrahim, S.2
-
11
-
-
66049149041
-
F9 Malmö, factor IX and deep vein thrombosis
-
Bezemer ID, Arellano AR, Tong C, Rowland CM, Ireland HA, Bauer KA, et al. F9 Malmö, factor IX and deep vein thrombosis. Haematologica 2009; 94:693-699
-
(2009)
Haematologica
, vol.94
, pp. 693-699
-
-
Bezemer, I.D.1
Arellano, A.R.2
Tong, C.3
Rowland, C.M.4
Ireland, H.A.5
Bauer, K.A.6
-
12
-
-
40949145685
-
Gene variants associated with deep vein thrombosis
-
Bezemer ID, Bare LA, Doggen CJM, Arellano AR, Tong C, Rowland CM, et al. Gene variants associated with deep vein thrombosis. JAMA 2008;299:1306-1314
-
(2008)
JAMA
, vol.299
, pp. 1306-1314
-
-
Bezemer, I.D.1
Bare, L.A.2
Doggen, C.J.M.3
Arellano, A.R.4
Tong, C.5
Rowland, C.M.6
-
13
-
-
0034072235
-
Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years. Relationships to hormone replacement therapy
-
Lowe G, Woodward M, Vessey M, Rumley A, Gough P, Daly E. Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years: relationships to hormone replacement therapy. Thromb Haemost 2000;83:530-535 (Pubitemid 30201125)
-
(2000)
Thrombosis and Haemostasis
, vol.83
, Issue.4
, pp. 530-535
-
-
Lowe, G.1
Woodward, M.2
Vessey, M.3
Rumley, A.4
Gough, P.5
Daly, E.6
-
14
-
-
0034660655
-
High levels of factor IX increase the risk of venous thrombosis
-
van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000;95:3678-3682 (Pubitemid 30412836)
-
(2000)
Blood
, vol.95
, Issue.12
, pp. 3678-3682
-
-
Van Hylckama Vlieg, A.1
Van Der Linden, I.K.2
Bertina, R.M.3
Rosendaal, F.R.4
-
15
-
-
0030860570
-
Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use
-
Lowe GDO, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, Tunstall-Pedoe H. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 1997; 97:775-784
-
(1997)
Br J Haematol
, vol.97
, pp. 775-784
-
-
Lowe, G.D.O.1
Rumley, A.2
Woodward, M.3
Morrison, C.E.4
Philippou, H.5
Lane, D.A.6
Tunstall-Pedoe, H.7
-
16
-
-
0030761812
-
Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease
-
Woodward M, Lowe GDO, Rumley A, Tunstall-Pedoe H, Philippou H, Lane DA, Morrison CE. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 1997;97:785-797
-
(1997)
Br J Haematol
, vol.97
, pp. 785-797
-
-
Woodward, M.1
Lowe, G.D.O.2
Rumley, A.3
Tunstall-Pedoe, H.4
Philippou, H.5
Lane, D.A.6
Morrison, C.E.7
-
17
-
-
38349093597
-
Relationship between markers of activated coagulation, their correlation with inflammation and association with coronary heart disease (NPHSII)
-
Miller GJ, Ireland HA, Cooper JA, Bauer KA, Morrissey JH, Humphries SE, Esnouf MP. Relationship between markers of activated coagulation, their correlation with inflammation and association with coronary heart disease (NPHSII). J Thromb Haemost 2008;6:259-267
-
(2008)
J Thromb Haemost
, vol.6
, pp. 259-267
-
-
Miller, G.J.1
Ireland, H.A.2
Cooper, J.A.3
Bauer, K.A.4
Morrissey, J.H.5
Humphries, S.E.6
Esnouf, M.P.7
-
18
-
-
54149087646
-
Less severe bleeding in hemophilia B than in hemophilia a
-
Lowe GD, Ludlam CA. Less severe bleeding in hemophilia B than in hemophilia A. J Thromb Haemost 2008;6:1982-1983.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 1982-1983
-
-
Lowe, G.D.1
Ludlam, C.A.2
-
19
-
-
43749099626
-
Fibrinogen gene variation and ischemic stroke
-
Jood K, Danielson J, Ladenvall C, Blomstrand C, Jern C. Fibrinogen gene variation and ischemic stroke. J Thromb Haemost 2008;6:897-904.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 897-904
-
-
Jood, K.1
Danielson, J.2
Ladenvall, C.3
Blomstrand, C.4
Jern, C.5
|